Jaguar Health Announces Reverse Stock Split for Nasdaq Compliance
Jaguar Health (NASDAQ: JAGX) announced its intention to execute a 1-for-15 reverse stock split on September 17, 2026. The move is aimed at bringing the company into compliance with Nasdaq's minimum closing bid price requirement of $1 per share. Shares have experienced significant volatility following the announcement as investors react to concerns about financial distress and potential delisting risks. The reverse stock split will reduce the number of outstanding shares, which could help stabilize the stock price by increasing its nominal value. However, such actions are often viewed negatively in the market due to their association with companies facing liquidity or operational challenges. Investors remain cautious as they assess whether this measure is sufficient for long-term stability. The company has not disclosed additional financial details beyond the split announcement.
Topics: Nasdaq compliance reverse stock split